Cancer Research Meeting Calendar  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 4927-4935, November 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jin, Z.
Right arrow Articles by Zarbl, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jin, Z.
Right arrow Articles by Zarbl, H.

Alterations in H-ras1 Promoter Conformation during N-Nitroso-N-methylurea-induced Mammary Carcinogenesis and Pregnancy1

Zhuang Jin2,3, Benoit Houle2,4, Andrei M. Mikheev2, Rita S. Cha5 and Helmut Zarbl6

Division of Public Health Services, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104-2092 [B. H. A. M. M. H. Z.], and Division of Toxicology and Center for Environmental Health Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 [Z. J., B. H., A. M. M., R. S. C. H. Z.]

We previously demonstrated that H-ras1 oncogene mutations detected in N-nitroso-N-methylurea (NMU)-induced mammary tumors arose as background mutations within rat mammary cells (RMCs) and that NMU promoted the outgrowth of these preexisting mutants. We have now detected a putative DNA structure in the H-ras1 promoter of RMCs in vivo that was absent in NMU-induced mammary tumor cells. Analysis of the promoter in RMCs as a function of time after exposure to carcinogens indicated that NMU, but not 7,12-dimethylbenz(a)anthracene, initiated the loss of this structure with a half-life of 7 days. Although loss of the structure was irreversible in cells that gave rise to tumors, it was restored in normal RMCs by 120 days after exposure and was present in normal RMCs of animals bearing tumors, even 1 year after NMU exposure. The structure was also abrogated in RMCs during pregnancy and restored after lactation was terminated, suggesting that reversible regulation of the structure by hormones contributed to normal RMC growth. Thus, NMU may promote abnormal RMC growth by mimicking the effects of hormones on DNA conformation. We hypothesize that the NMU-induced alterations in promoter conformation irreversibly deregulates H-ras1 expression in initiated cells, thereby increasing the phenotypic penetrance of the conditional H-ras1 mutations.

1 This study was supported by NIH Program Project Grant ES 05622 (William G. Thilly) awarded to the MIT Center for Environmental Health Sciences and Cancer Center Core Grant CA 15704 (Robert Day) awarded to the Fred Hutchinson Cancer Research Center. B. H. was the recipient of a postdoctoral fellowship from the Fonds de la Recherche en Santé du Québec, Quebec, Canada.

2 These authors contributed equally to the design, execution, and interpretation of the experiments described in this study.

3 Present address: Division of Allergy-Immunology, Cornell University Medical College, 1300 York Avenue, New York, NY 10021.

4 Present address: Institut du Cancer de Montreal, Centre de Recherche Louis-Charles Simard, Hôpital Notre Dame, Montreal, Quebec, H2L 4M1 Canada.

5 Present address: Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115.

6 To whom requests for reprints should be addressed, at Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Room C1-211, Mailstop C1-015, 1124 Columbia Street, Seattle, WA 98104-2092. Phone: (206) 667-4107; Fax: (206) 667-5815.

Received 6/14/96. Accepted 9/ 5/96.




This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
X. Zhang and H. Zarbl
Chemopreventive Doses of Methylselenocysteine Alter Circadian Rhythm in Rat Mammary Tissue
Cancer Prevention Research, July 1, 2008; 1(2): 119 - 127.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. M. Mikheev, S. A. Mikheev, Y. Zhang, R. Aebersold, and H. Zarbl
CArG binding factor A (CBF-A) is involved in transcriptional regulation of the rat Ha-ras promoter
Nucleic Acids Res., October 1, 2000; 28(19): 3762 - 3770.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Chow and H. Rubin
The cellular ecology of progressive neoplastic transformation: A clonal analysis
PNAS, March 2, 1999; 96(5): 2093 - 2098.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.